BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18580231)

  • 1. F-18 fluorodeoxyglucose (FDG) PET in the diagnosis of malignant transformation of fibrous dysplasia in the pelvic bones.
    Berrebi O; Steiner C; Keller A; Rougemont AL; Ratib O
    Clin Nucl Med; 2008 Jul; 33(7):469-71. PubMed ID: 18580231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrous dysplasia of the bone. Contribution of nuclear medicine in the diagnosis of suspicion of sarcomatous degeneration].
    Santiago Chinchilla A; Ramos Font C; Tello Moreno M; Rebollo Aguirre AC; Navarro-Pelayo Láinez M; Gallego Peinado M; Llamas Elvira JM
    Rev Esp Med Nucl; 2010; 29(4):172-6. PubMed ID: 20138408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18 F-FDG avid lesion due to coexistent fibrous dysplasia in a child of embryonal rhabdomyosarcoma: source of false positive FDG-PET.
    Basu S; Baghel NS; Puri A; Shet T; Merchant NH
    J Cancer Res Ther; 2010; 6(1):92-4. PubMed ID: 20479556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imaging.
    Charest M; Singnurkar A; Hickeson M; Novales JA; Derbekyan V
    Clin Nucl Med; 2008 Jul; 33(7):455-8. PubMed ID: 18580228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET-positive polyostotic fibrous dysplasia mimicking Ollier disease.
    Nishio J; Kuwabara Y; Nabeshima S; Iwasaki H; Naito M
    In Vivo; 2013; 27(6):821-6. PubMed ID: 24292588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrous Dysplasia Presenting as a Cold Spot in 18F-FLT PET/CT Imaging.
    Rehak Z; Bencsikova B; Zambo I; Kazda T
    Clin Nucl Med; 2016 Jun; 41(6):510-1. PubMed ID: 27055128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of FDG PET activity of fibrous dysplasia of the skull late in life mimicking metastatic disease.
    Bonekamp D; Jacene H; Bartelt D; Aygun N
    Clin Nucl Med; 2008 Dec; 33(12):909-11. PubMed ID: 19033807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant Sarcomatous Degeneration of Craniofacial Fibrous Dysplasia.
    Hussaini AS; Swanson DD; Nguy PL; Pan KS; de Castro LF; Boyce AM; Collins MT; DeKlotz TR
    J Craniofac Surg; 2022 Sep; 33(6):1787-1790. PubMed ID: 36054890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally aggressive fibrous dysplasia mimicking malignancy: a report of four cases and review of the literature.
    Muthusamy S; Subhawong T; Conway SA; Temple HT
    Clin Orthop Relat Res; 2015 Feb; 473(2):742-50. PubMed ID: 25212962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrous dysplasia and McCune-Albright syndrome: case-report and differential diagnose with Paget bone disease].
    Silva I; Mateus M; Branco JC
    Acta Reumatol Port; 2010; 35(5):497-503. PubMed ID: 21245817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scoliosis and spine involvement in fibrous dysplasia of bone.
    Mancini F; Corsi A; De Maio F; Riminucci M; Ippolito E
    Eur Spine J; 2009 Feb; 18(2):196-202. PubMed ID: 19130098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The appearance of Mazabraud's syndrome on 18F-FDG PET/CT.
    Singnurkar A; Phancao JP; Chatha DS; Stern J
    Skeletal Radiol; 2007 Nov; 36(11):1085-9. PubMed ID: 17589842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary osteosarcoma arising in fibrous dysplasia, case report.
    Doganavsargil B; Argin M; Kececi B; Sezak M; Sanli UA; Oztop F
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):439-44. PubMed ID: 18560851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. McCune-Albright Syndrome: intensely hypermetabolic polyostotic fibrous dysplasia on F-18 FDG-PET.
    Saxon PH; Scalcione LR; Luongo JA; Luchs JS; Mazzie JP; Katz DS; Yung EY
    Clin Nucl Med; 2009 Nov; 34(11):795-7. PubMed ID: 19851179
    [No Abstract]   [Full Text] [Related]  

  • 15. F-18 fluorodeoxyglucose positron emission tomography finding of Mazabraud syndrome.
    Miyake M; Tateishi U; Maeda T; Arai Y; Seki K; Hasegawa T; Sugimura K
    Clin Nucl Med; 2006 Oct; 31(10):627-9. PubMed ID: 16985371
    [No Abstract]   [Full Text] [Related]  

  • 16. Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
    van der Bruggen W; Vriens D; Meier ME; Smit F; Winter EM; de Geus-Oei LF; Appelman-Dijkstra NM
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2980-e2994. PubMed ID: 33788944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mazabraud's Syndrome Mimicking Metastases on FDG PET/CT in a Patient With Colon Cancer.
    Mahajan S; Goel R; Riedl C; Ulaner GA
    Clin Nucl Med; 2018 Aug; 43(8):625-626. PubMed ID: 29863575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
    Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
    J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. McCune-Albright syndrome: the patterns of scintigraphic abnormalities.
    Pfeffer S; Molina E; Feuillan P; Simon TR
    J Nucl Med; 1990 Sep; 31(9):1474-8. PubMed ID: 2395015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of bone scan in the McCune-Albright syndrome. Report of a case.
    Edeburn GF; Mortensson W
    Acta Radiol Diagn (Stockh); 1986; 27(6):719-21. PubMed ID: 3812022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.